duit Pharmaceuticals (CDT) - 2024 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the quarterly period ended March 31, 2024 For the transition period from to | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------| | Delaware \n(State or other jurisdiction of incorporation or organization) \n4995 Murphy Canyon Road, Suit ...